OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $131,000 | +15.9% | 20,100 | +64.8% | 0.01% | +125.0% |
| Q1 2017 | $113,000 | -36.2% | 12,200 | -42.5% | 0.00% | -85.2% |
| Q4 2016 | $177,000 | +52.6% | 21,200 | +25.4% | 0.03% | -15.6% |
| Q3 2016 | $116,000 | +114.8% | 16,900 | +53.6% | 0.03% | -57.3% |
| Q2 2016 | $54,000 | -90.8% | 11,000 | -60.8% | 0.08% | -47.9% |
| Q2 2015 | $590,000 | +100.7% | 28,068 | +301.0% | 0.14% | +136.1% |
| Q1 2015 | $294,000 | – | 7,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |